PubRank

Ximing J Yang

Author PubWeight™ 101.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 2011 2.78
2 Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol 2006 1.87
3 Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004 1.85
4 MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009 1.68
5 Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007 1.66
6 Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One 2008 1.64
7 Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010 1.61
8 Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology 2002 1.52
9 Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med 2006 1.52
10 Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol 2008 1.49
11 Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res 2004 1.47
12 Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression. Urology 2006 1.44
13 Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003 1.42
14 The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 2008 1.33
15 Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol 2009 1.31
16 Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol 2007 1.22
17 Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 2005 1.21
18 P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002 1.21
19 Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005 1.20
20 MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 2009 1.20
21 Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 2005 1.19
22 Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 2004 1.17
23 Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res 2009 1.16
24 Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol 2009 1.15
25 Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol 2006 1.14
26 A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006 1.13
27 Predictors of response to targeted therapy in renal cell carcinoma. Arch Pathol Lab Med 2012 1.10
28 Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 2007 1.10
29 Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 2010 1.08
30 Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 2007 1.08
31 C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 2005 1.08
32 TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One 2011 1.08
33 Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 2006 1.08
34 Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol 2004 1.08
35 Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate 2005 1.07
36 Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002 1.06
37 Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med 2008 1.06
38 Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 2010 1.06
39 Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther 2006 1.05
40 Renal medullary carcinoma and ABL gene amplification. J Urol 2005 1.05
41 Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 2004 1.05
42 Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas. Ann Clin Lab Sci 2006 1.04
43 Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics 2010 1.03
44 Minor modifications in apical dissection of radical retropubic prostatectomy in patients with clinical stage T2 prostate cancer reduce positive surgical margin incidence. Urology 2004 1.02
45 Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004 1.00
46 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther 2008 0.99
47 Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol 2006 0.98
48 Expression analysis of putative stem cell markers in human benign and malignant prostate. Prostate 2011 0.96
49 Expression of S-100 protein in renal cell neoplasms. Hum Pathol 2006 0.95
50 Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol 2008 0.95
51 Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol 2007 0.94
52 c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol 2005 0.92
53 Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol 2008 0.92
54 Computer-aided identification of prostatic adenocarcinoma: Segmentation of glandular structures. J Pathol Inform 2011 0.92
55 Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol 2006 0.91
56 Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch Pathol Lab Med 2013 0.91
57 Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 2013 0.91
58 Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Am J Clin Pathol 2008 0.91
59 The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors. J Urol 2007 0.91
60 Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients. Clin Cancer Res 2010 0.90
61 The methodology used to measure differential gene expression affects the outcome. J Biomol Tech 2007 0.90
62 Recurrent giant cell carcinoma of the bladder. J Urol 2002 0.90
63 Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol 2007 0.90
64 p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer 2010 0.89
65 Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol 2006 0.88
66 High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol 2014 0.87
67 Computer-aided detection of prostate cancer on tissue sections. Appl Immunohistochem Mol Morphol 2009 0.87
68 Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol 2008 0.87
69 Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression. Prostate 2010 0.86
70 Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol 2005 0.85
71 Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol 2004 0.85
72 P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol 2004 0.84
73 Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med 2007 0.84
74 The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. PLoS One 2012 0.84
75 Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2006 0.83
76 Expression of glypican 3 in placental site trophoblastic tumor. Diagn Pathol 2010 0.83
77 Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 2005 0.83
78 Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus. Am J Clin Pathol 2008 0.83
79 Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature. Can J Urol 2007 0.82
80 Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses. Clin Genitourin Cancer 2006 0.81
81 Prevalence of high-grade prostatic intraepithelial neoplasia and its relationship to serum prostate specific antigen. Int Braz J Urol 2005 0.81
82 Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas. Appl Immunohistochem Mol Morphol 2004 0.81
83 A unique renal cell carcinoma with features of papillary renal cell carcinoma and thyroid-like carcinoma: a morphological, immunohistochemical and genetic study. Histopathology 2010 0.81
84 Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer. JAMA 2002 0.81
85 Angiosarcoma masquerading as embryonal carcinoma in the metastasis from a mature testicular teratoma. Arch Pathol Lab Med 2003 0.80
86 FXYD3: A Promising Biomarker for Urothelial Carcinoma. Biomark Insights 2011 0.79
87 Protein markers of malignant potential in penile and vulvar lichen sclerosus. J Urol 2013 0.79
88 Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nat Rev Urol 2010 0.79
89 Pathogenesis and significance of collagenous micronodules of the prostate. Appl Immunohistochem Mol Morphol 2003 0.78
90 P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 2005 0.78
91 Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am J Surg Pathol 2015 0.78
92 Expression of carbonic anhydrase IX in genitourinary and adrenal tumours. Histopathology 2011 0.78
93 Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Arch 2014 0.78
94 Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma. Int Braz J Urol 2007 0.77
95 Clinical utility of delayed-contrast computed tomography for tissue characterization of cardiac thrombus. J Cardiovasc Comput Tomogr 2007 0.77
96 Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate. Am J Clin Pathol 2006 0.77
97 Discovery and diagnostic value of a novel oncofetal protein: glypican 3. Adv Anat Pathol 2014 0.77
98 Reversible demyelinating neuropathy associated with renal cell carcinoma. Neuromuscul Disord 2010 0.77
99 Immunohistochemical evaluation of ERG expression in various benign and malignant tissues. Ann Clin Lab Sci 2013 0.77
100 Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy. Am J Clin Pathol 2005 0.77
101 Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications. Urology 2004 0.76
102 Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt-Hogg-Dubé syndrome: a case report. Acta Cytol 2006 0.75
103 Primary amyloidosis of the bladder treated with partial cystectomy. Can J Urol 2003 0.75
104 [Alpha-methylacyl-CoA racemase: a useful marker for diagnosis of prostatic carcinoma]. Zhonghua Bing Li Xue Za Zhi 2004 0.75
105 Trends in prostatic adenocarcinoma tumor volume by visual estimation in prostatectomy specimens. Pathol Res Pract 2012 0.75
106 Practical Applications of Immunohistochemistry in the Diagnosis of Genitourinary Tumors. Arch Pathol Lab Med 2017 0.75
107 [Non-clear cell renal carcinoma: comparative analysis of the new and old histological classification in 79 cases]. Zhonghua Zhong Liu Za Zhi 2010 0.75
108 Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists. Am J Surg Pathol 2015 0.75
109 Topoisomerase II alpha expression in testicular germ cell tumors. Urology 2007 0.75